Showing results (171-180 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|March 14, 2014
Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trialHelena W Rodbard, Virginia E Visco, Henning Andersen, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trialWenying Yang, Jie Liu, Zhongyan Shan, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgeryDavid E Cummings, Ricardo V Cohen
The Lancet. Diabetes & Endocrinology|March 14, 2014
Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort studyRichard H Tuligenga, Aline Dugravot, Adam G Tabák, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Depression and type 2 diabetes: a causal association?Adam G Tabák, Tasnime N Akbaraly, G David Batty, et al.
The Lancet. Diabetes & Endocrinology|April 8, 2014
Turner's syndrome: challenges of late diagnosisMarilyn Cheng Lee, Gerard S Conway
The Lancet. Diabetes & Endocrinology|January 30, 2017
Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetesEberhard Standl, Oliver Schnell, Darren K McGuire, et al.
The Lancet. Diabetes & Endocrinology|November 20, 2016
Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) studyBethany Warren, James S Pankow, Kunihiro Matsushita, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2016
Effectiveness of activity trackers with and without incentives to increase physical activity (TRIPPA): a randomised controlled trialEric A Finkelstein, Benjamin A Haaland, Marcel Bilger, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2016
Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysisSanjay Basu, Vishnu Shankar, John S Yudkin
Pageof 93